The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics

The Chinese Hypertension Intervention Efficacy Study (CHIEF) is a multi-centre randomized controlled clinical trial comparing the effects of amlodipine+angiotensin II receptor blocker and amlodipine+diuretics on the incidence of cardiovascular events, represented as a composite of non-fatal stroke,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, W, Ma, L, Zhang, Y, Deng, Q, Liu, M, Liu, L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061000/
https://www.ncbi.nlm.nih.gov/pubmed/20445570
http://dx.doi.org/10.1038/jhh.2010.45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061000/
https://www.ncbi.nlm.nih.gov/pubmed/20445570
http://dx.doi.org/10.1038/jhh.2010.45

Ejemplares similares